(Q40105215)

English

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

scientific article

Statements

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial (English)
David A Margolis
Juan Gonzalez-Garcia
Thomas Lutz
Jonathan B Angel
Gary J Richmond
Felix Gutierrez
Louis Sloan
Marty St Clair
Miranda Murray
Susan L Ford
Joseph Mrus
Parul Patel
Herta Crauwels
Sandy K Griffith
Kenneth C Sutton
David Dorey
Kimberly Y Smith
Peter E Williams
William R Spreen
21 July 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit